Envista (NVST) Total Debt to Capital

Envista Holdings (NVST) - corporate logo

The daily price chart for Envista Holdings (NVST) reflects a total debt-to-equity ratio of 0.54. Envista Holdings (NVST) is implementing eco-friendly packaging and equipment recycling in accordance with ESG standards. The business relies on the supply of implants and orthodontic systems to dental centers. Currently, the strategy focuses on acquiring intraoral scanner developers to stimulate growth through targeted technological deals.

NVST: envistaco.com Debt to Equity Ratio 07/04/2022 - 11/01/2026

Analytical breakdowns for Envista Holdings

- price and consensus price forecast:
Price Chart Envista|NVST - Consensus Target
- market capitalization details:
Market Capitalization Envista|NVST - Total Enterprise Value
- book capitalization indicators:
Book Value per Share Envista|NVST - Accounting Capitalization|Market Capitalization to Book Value Ratio envistaco.com|NVST - Company Total Asset Base
- issuer credit burden and liquidity indicators:
Total Debt to Capital Envista Holdings|NVST - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Envista Holdings|NVST - Company Aggregate Debts|Debt to Book Capitalization Ratio Envista|NVST - Company Long-Term Debt|Company Current Liabilities Envista|Quick Ratio envistaco.com
- earnings and valuation multiples information:
NVST - Net Financial Result
Basic company analysis:NVST, Envista
Finished products of Nobel Biocare

Envista Holdings (NVST) transition to digital 3D scanning and eco-friendly sterilization requires capital expenditures, the dynamics of which are reflected through the lens of GURU.Markets via the total debt-to-equity ratio. This metric compares total liabilities to net assets, allowing investors to assess the degree of financial leverage: a decrease in the indicator confirms growing business autonomy, although it may temporarily limit the return on invested capital.

Key competitors

Debt to Equity Intuitive|Total Debt to Equity Ratio Danaher Corporation (DHR)|Total Debt to Capital BDX|STE - Debt to Capital|Total Debt to Capital WST (West Pharmaceutical Services)|BAX: Debt to Equity Ratio|Masimo - Total Debt to Capital|Total Debt to Capital Coefficient Stevanato Group SpA STVN|TFX: Total Debt to Capital|Total Debt to Equity Ratio Merit Medical Corp|ICUI (ICU Medical, Inc.) - Total Debt to Capital|Total Debt to Capital dentsplysirona.com|Debt to Equity LeMaitre Vascular (LMAT)|Debt to Equity ATRC (AtriCure Inc)|STAAR Surgical Corp - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio NAGE|ZimVie Inc. - Total Debt to Capital|Total Debt to Capital Coefficient angiodynamics.com ANGO|Cerus (CERS) - Debt to Equity|Debt to Equity Ratio TKNO|Debt to Equity Monogram Technologies Inc|Sharps Tech (STSS) - Total Debt to Capital Coefficient|Total Debt to Equity Ratio INFU (InfuSystem Holdings)|Aggregate Debt to Capital UTMD|Debt to Equity KORU Medical KRMD|All Debt to Shareholders' Equity Ratio NYXH|MBOT: Total Debt to Equity Ratio|PDEX - Total Debt to Capital|Zentek Ltd. (ZTEK) - Debt to Equity|Total Debt to Equity Ratio elutia.com|MLSS (Milestone Scientific Inc.) - Total Debt to Capital|Debt to Capital NEXGEL Inc. NXGL|Debt to Equity Retractable Technologies (RVP)|harvardbioscience.com - Debt to Equity Ratio|Femasys Inc. - Total Debt to Equity Ratio|Aggregate Debt to Capital MHUA (Meihua Medical Technologies)|POAI - Debt to Equity|Total Debt to Capital Coefficient Callan JMB Inc CJMB|ATRI: Total Debt to Capital|Debt to Capital NeuroMetrix Corporation (NURO)